X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9875) 9875
Magazine Article (35) 35
Book Chapter (27) 27
Book / eBook (13) 13
Newsletter (4) 4
Newspaper Article (3) 3
Web Resource (3) 3
Conference Proceeding (2) 2
Government Document (2) 2
Book Review (1) 1
Dissertation (1) 1
Paper (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9041) 9041
male (4597) 4597
female (4460) 4460
community-acquired infections - drug therapy (4437) 4437
anti-bacterial agents - therapeutic use (3936) 3936
community-acquired pneumonia (3798) 3798
middle aged (3246) 3246
aged (3164) 3164
infectious diseases (3097) 3097
adult (3036) 3036
pneumonia (2860) 2860
community-acquired infections - microbiology (2789) 2789
microbiology (1973) 1973
community-acquired infections - epidemiology (1874) 1874
risk factors (1809) 1809
antibiotics (1719) 1719
aged, 80 and over (1620) 1620
adolescent (1589) 1589
pneumonia, bacterial - drug therapy (1560) 1560
mortality (1524) 1524
treatment outcome (1522) 1522
pharmacology & pharmacy (1447) 1447
bacterial pneumonia (1436) 1436
pneumonia - drug therapy (1327) 1327
infections (1318) 1318
child (1309) 1309
retrospective studies (1297) 1297
management (1275) 1275
medicine, general & internal (1248) 1248
community-acquired infections - diagnosis (1225) 1225
epidemiology (1217) 1217
health aspects (1180) 1180
microbial sensitivity tests (1161) 1161
prospective studies (1077) 1077
child, preschool (1054) 1054
anti-bacterial agents - pharmacology (1042) 1042
guidelines (988) 988
respiratory system (981) 981
research (949) 949
adults (941) 941
diagnosis (926) 926
anti-bacterial agents - administration & dosage (903) 903
infant (902) 902
hospitalization (882) 882
children (862) 862
therapy (838) 838
care and treatment (836) 836
community-acquired infections (828) 828
drug resistance, bacterial (782) 782
immunology (762) 762
staphylococcus aureus (734) 734
hospitals (727) 727
drug therapy (719) 719
internal medicine (718) 718
cross infection - microbiology (714) 714
streptococcus-pneumoniae (713) 713
risk-factors (695) 695
community-acquired infections - mortality (686) 686
cross infection - drug therapy (680) 680
pneumonia, bacterial - microbiology (678) 678
prognosis (667) 667
severity of illness index (649) 649
pediatrics (646) 646
young adult (640) 640
staphylococcal infections - drug therapy (625) 625
prevalence (607) 607
infection (598) 598
staphylococcal infections - microbiology (596) 596
antimicrobial resistance (581) 581
analysis (577) 577
drug resistance in microorganisms (562) 562
methicillin resistance (552) 552
outcomes (541) 541
respiratory tract infections - drug therapy (538) 538
cross infection - epidemiology (523) 523
incidence (514) 514
bacteremia (507) 507
drug resistance (505) 505
staphylococcal infections - epidemiology (489) 489
critical care medicine (482) 482
infectious disease (479) 479
abridged index medicus (478) 478
practice guidelines as topic (470) 470
etiology (466) 466
united-states (459) 459
staphylococcus aureus - drug effects (450) 450
bacteria (446) 446
pathogens (446) 446
sepsis (431) 431
anti-infective agents - therapeutic use (422) 422
cohort studies (422) 422
resistance (420) 420
patients (417) 417
medicine (413) 413
respiratory-tract infections (405) 405
streptococcus pneumoniae - drug effects (397) 397
medicine & public health (395) 395
bacterial infections - drug therapy (389) 389
pneumonia, bacterial - diagnosis (386) 386
pneumonia - diagnosis (381) 381
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9257) 9257
Spanish (275) 275
French (238) 238
German (108) 108
Japanese (96) 96
Russian (85) 85
Portuguese (57) 57
Chinese (40) 40
Dutch (23) 23
Italian (23) 23
Turkish (17) 17
Polish (14) 14
Romanian (6) 6
Swedish (5) 5
Ukrainian (5) 5
Hebrew (4) 4
Croatian (3) 3
Czech (3) 3
Danish (3) 3
Hungarian (3) 3
Bosnian (1) 1
Finnish (1) 1
Icelandic (1) 1
Korean (1) 1
Latvian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of respiratory and critical care medicine, ISSN 1535-4970, 2019, Volume 200, Issue 7, pp. e45 - e67
...: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions... 
LOW-RISK PATIENTS | SUSPECTED PNEUMOCOCCAL PNEUMONIA | VENTILATOR-ASSOCIATED PNEUMONIA | CARE-ASSOCIATED PNEUMONIA | BETA-LACTAM MONOTHERAPY | community-acquired pneumonia | RESISTANT STAPHYLOCOCCUS-AUREUS | SPUTUM GRAM STAIN | MILD-TO-MODERATE | pneumonia | RESPIRATORY SYSTEM | CRITICALLY-ILL PATIENTS | patient management | HIGH-DOSAGE AMOXICILLIN | CRITICAL CARE MEDICINE | Community-Acquired Infections - diagnosis | Culture Techniques | United States | Humans | Pneumonia, Pneumococcal - diagnosis | Haemophilus Infections - diagnosis | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Adult | Haemophilus Infections - metabolism | Drug Therapy, Combination | Haemophilus Infections - drug therapy | Pneumonia, Mycoplasma - metabolism | Severity of Illness Index | Chlamydophila Infections - drug therapy | Blood Culture | Chlamydophila Infections - metabolism | Legionellosis - diagnosis | Hospitalization | Legionellosis - drug therapy | Pneumonia, Bacterial - diagnosis | Ambulatory Care | Moraxellaceae Infections - drug therapy | Chlamydophila Infections - diagnosis | Pneumonia, Pneumococcal - metabolism | Antigens, Bacterial - urine | Pneumonia, Staphylococcal - drug therapy | Moraxellaceae Infections - metabolism | Pneumonia, Staphylococcal - diagnosis | Pneumonia, Staphylococcal - metabolism | Sputum | Pneumonia, Bacterial - drug therapy | Legionellosis - metabolism | Pneumonia, Pneumococcal - drug therapy | Radiography, Thoracic | Moraxellaceae Infections - diagnosis | Macrolides - therapeutic use | beta-Lactams - therapeutic use | Pneumonia, Mycoplasma - diagnosis | Pneumonia, Mycoplasma - drug therapy
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 3, p. e91713
...) in a network of community hospitals and 2) determine risk factors for inappropriate therapy for bloodstream infections in community hospitals... 
METHICILLIN-RESISTANT | MORTALITY | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | ANTIMICROBIAL TREATMENT | VALIDATION | PREVENTION | STAPHYLOCOCCUS-AUREUS BACTEREMIA | ENDOCARDITIS | EPIDEMIOLOGY | SEVERITY | United States - epidemiology | Pseudomonas aeruginosa - isolation & purification | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Pseudomonas aeruginosa - growth & development | Drug Resistance, Bacterial | Male | Hospitals, Community | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Escherichia coli - growth & development | Cross Infection - epidemiology | Medication Errors | Staphylococcal Infections - drug therapy | Staphylococcus aureus - isolation & purification | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Staphylococcal Infections - epidemiology | Escherichia coli - isolation & purification | Cross Infection - microbiology | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Aged | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Community-Acquired Infections - microbiology | Health care | Therapy | Pediatrics | Communities | Physicians | Infections | Drug resistance | Epidemiology | Antiinfectives and antibacterials | Risk factors | Data dictionaries | 21st century | E coli | Trends | Nosocomial infections | Medical personnel | Pathogens | Coagulase | Comorbidity | Mortality | Staphylococcus infections | Antimicrobial agents | Risk analysis | Patients | Disease control | Studies | Infectious diseases | Hospitals | Endocarditis
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2010, Volume 51, Issue S2, pp. S183 - S197
...) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide... 
Osteomyelitis | Infectious diseases | Antibiotics | Antimicrobials | Endocarditis | Abscesses | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | HEALTH-CARE SETTINGS | INFECTIOUS DISEASES | ANTIMICROBIAL THERAPY | LINEZOLID PNU-100766 | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | CLINDAMYCIN TREATMENT | MICROBIOLOGY | IMMUNOLOGY | INTRANASAL MUPIROCIN | COMPLICATED SKIN | 2 DOUBLE-BLIND | SKIN-STRUCTURE INFECTIONS | NOSOCOMIAL PNEUMONIA | Community-Acquired Infections - diagnosis | Staphylococcal Infections - pathology | Humans | Osteomyelitis - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Cross Infection - pathology | Endocarditis, Bacterial - pathology | Community-Acquired Infections - drug therapy | Osteomyelitis - pathology | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Bacteremia - drug therapy | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Cross Infection - drug therapy | Staphylococcal Infections - diagnosis | Osteomyelitis - diagnosis | Community-Acquired Infections - pathology | Osteomyelitis - microbiology | Cross Infection - microbiology | Cross Infection - diagnosis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteremia - pathology | Community-Acquired Infections - microbiology
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 7, p. e69581
Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by extended-spectrum beta-lactamase (ESBL... 
ESCHERICHIA-COLI STRAINS | NEW-ZEALAND | (ESBL)-PRODUCING ENTEROBACTERIA | MULTIDISCIPLINARY SCIENCES | NONHOSPITALIZED PATIENTS | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | ONSET | Multivariate Analysis | Demography | Klebsiella pneumoniae - drug effects | Prevalence | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Male | beta-Lactamases - biosynthesis | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Community-Acquired Infections - drug therapy | Klebsiella pneumoniae - genetics | Female | Urinary Tract Infections - microbiology | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Klebsiella Infections - drug therapy | Drug Resistance, Microbial - drug effects | Risk Factors | Escherichia coli Infections - microbiology | Genotype | Logistic Models | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Escherichia coli - genetics | Norway - epidemiology | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology | Medical research | Medicine, Experimental | Urinary tract infections | Beta lactamases | Diabetes | Behavior | Health aspects | Prevalence studies (Epidemiology) | Fluoroquinolones | Laboratories | Communities | Amdinocillin | Diabetes mellitus | Fish meal | Population studies | Infections | Urinary tract | Risk analysis | Drug resistance | Epidemiology | Risk factors | Confidence intervals | Studies | E coli | Fish | Swimming | Meals | Community medicine, Social medicine: 801 | Samfunnsmedisin, sosialmedisin: 801 | VDP | Basic medical, dental and veterinary science disciplines: 710 | Medical microbiology: 715 | Helsefag: 800 | Health sciences: 800 | Medisinske Fag: 700 | Medisinsk mikrobiologi: 715 | Medical disciplines: 700 | Basale medisinske, odontologiske og veterinærmedisinske fag: 710
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1744-7666, 2014, Volume 16, Issue 2, pp. 159 - 177
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 2, p. CD003543
Journal Article